Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-02-28 07:30 |
À L'OCCASION DE LA JOURNÉE MONDIALE DES MALADIES RARES 2022, THERANEXUS DÉVOILE…
|
French | 576.2 KB | ||
| 2022-02-28 07:30 |
THERANEXUS UNVEILS ITS SCIENTIFIC ADVANCES ON THE OCCASION OF WORLD RARE DISEAS…
|
English | 543.3 KB | ||
| 2022-02-10 18:40 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 275.2 KB | ||
| 2022-02-03 18:00 |
THERANEXUS ET LA FONDATION BBDF INITIENT LE RECRUTEMENT POUR L'ÉTUDE DE PHASE I…
|
French | 388.7 KB | ||
| 2022-02-03 18:00 |
THERANEXUS AND BBDF START RECRUITMENT FOR PHASE I/II TRIAL IN BATTEN DISEASE PA…
|
English | 378.7 KB | ||
| 2022-01-13 18:00 |
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2021 - MISE EN PLACE…
|
French | 358.8 KB | ||
| 2022-01-13 18:00 |
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2021 - IMPLEMENTATION …
|
English | 355.0 KB | ||
| 2022-01-06 18:00 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 2ND SEMESTRE 2021
|
French | 382.8 KB | ||
| 2022-01-04 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 278.5 KB | ||
| 2021-12-20 18:00 |
THERANEXUS PUBLIE SON AGENDA FINANCIER 2022
|
French | 296.3 KB | ||
| 2021-12-20 18:00 |
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2022
|
English | 271.1 KB | ||
| 2021-12-13 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 277.6 KB | ||
| 2021-11-15 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 276.1 KB | ||
| 2021-10-19 18:00 |
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 SEPTEMBER 2021 AND PRESENTS ITS…
|
English | 1.4 MB | ||
| 2021-10-19 18:00 |
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 SEPTEMBRE 2021 ET FAIT LE POI…
|
French | 1.5 MB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
